Horizon Pharma reported $670.18M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbvie ABBV:US $ 9517M 1089M
Aerie Pharmaceuticals AERI:US $ 23.06M 85.54M
Amgen AMGN:US $ 4677M 451M
AstraZeneca AZN:LN 9.11B 169M
Bristol Myers Squibb BMY:US $ 9177M 452M
Coherus Biosciences CHRS:US $ 50.74M 10.52M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Endo International Ordinary Shares ENDP:US $ 472.5M 94.46M
Horizon Pharma HZNP:US $ 670.18M 102.77M
JAZZ PHA JAZZ:US $ 698.44M 62.14M
Merk MRK:US $ 10567M 873M
Novartis NOVN:VX 9.06B 463M
Pacira Pharmaceuticals PCRX:US $ 121.92M 1.73M
Perrigo Ordinary Shares PRGO:US $ 337.8M 24.6M
Pfizer PFE:US $ 15651M 1627M
Prestige Brands PBH:US $ 148.86M 6.2M
Revance Therapeutics RVNC:US $ 17.37M 701K
Supernus Pharmaceuticals SUPN:US $ 134.57M 7.48M
Takeda 4502:JP Y 564909M 54981M
Teva Pharmaceutical Industries TEVA:US $ 1802M 323M
Valeant Pharmaceuticals VRX:CN $ 1367M 203M
Xeris Pharmaceuticals Inc XERS:US $ 15.8M 740K
Zoetis ZTS:US $ 1421M 50M